Canada Markets open in 2 hrs 19 mins

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1850-0.0050 (-2.63%)
At close: 03:48PM EDT
Full screen
Previous Close0.1900
Open0.1900
Bid0.1850 x 0
Ask0.1900 x 0
Day's Range0.1800 - 0.1900
52 Week Range0.1300 - 0.5300
Volume105,000
Avg. Volume49,945
Market Cap12.787M
Beta (5Y Monthly)0.06
PE Ratio (TTM)N/A
EPS (TTM)-0.0460
Earnings DateJul 13, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.00
  • GlobeNewswire

    DIAGNOS Announces Closing of Private Placement

    BROSSARD, Quebec, Sept. 01, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that it has closed a non-brokered private placement (“Private Placement”) of 35 units (each a “Unit”) issued at a price of $10,000 per Unit for gross proceeds of $350,000. Each Unit consists of: One unsecured convertible Deb

  • GlobeNewswire

    DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems

    BROSSARD, Quebec, Aug. 18, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce the receipt of approval from the Costa Rican regulatory agency (Ministerio de Salud) for its Artificial Intelligence enabled Pathology Detection Systems. DIAGNOS’ platform has been approved for having complied

  • GlobeNewswire

    DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics

    BROSSARD, Quebec, July 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to continue its expansion in Canada with the kick-off of its services in endocrinology clinics with distribution partner Labtician Ophthalmics. DIAGNOS is announcing the kick-off by Labtician Ophthalmics (“Labtician”) of